135 related articles for article (PubMed ID: 27766305)
1. Primary cutaneous apocrine carcinoma: 2 cases and review of the pertinent histologic findings.
Schweitzer J; Vermeesch J; Zaleski T; Iacco M; Krach K; Ghaferi J; Cotton J
JAAD Case Rep; 2016 Sep; 2(5):411-414. PubMed ID: 27766305
[No Abstract] [Full Text] [Related]
2. Cutaneous metastases from breast carcinoma: calretinin expression and estrogen, progesterone and Her2/neu status of the metastases, compared to primary cutaneous apocrine tumors.
Fernandez-Flores A
Rom J Morphol Embryol; 2013; 54(3 Suppl):695-9. PubMed ID: 24322014
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated cutaneous apocrine carcinomas: histopathological clues and immunohistochemical analysis for the diagnosis of this unusual neoplasm.
Plaza JA; Brenn T; Gru AA; Matoso A; Sheldon J; Sangueza M
Histopathology; 2023 Jan; 82(2):276-284. PubMed ID: 36178027
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and morphologic evaluation of primary cutaneous apocrine carcinomas and cutaneous metastases from ductal breast carcinoma.
Fernandez-Flores A
Rom J Morphol Embryol; 2012; 53(4):879-92. PubMed ID: 23303010
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.
Furudate S; Fujimura T; Tsukada A; Sato Y; Hidaka T; Tanita K; Kambayashi Y; Haga T; Hashimoto A; Aiba S
Case Rep Oncol; 2017; 10(1):52-56. PubMed ID: 28203164
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Apocrine Carcinoma With an In Situ Component and Histiocytoid and Signet-Ring Cells.
Berdugo J; Dumont-Mackay V; Brissy-Lachery S; Leclerc YE; Doyon J; Mitchell A; Petrella T; Désy D
Am J Dermatopathol; 2017 Jun; 39(6):e76-e78. PubMed ID: 28525910
[TBL] [Abstract][Full Text] [Related]
7. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous adnexal carcinoma with apocrine differentiation.
Prasad V; Kao WH; Kao GF
Cutis; 2016 Dec; 98(6):E16-E19. PubMed ID: 28099545
[TBL] [Abstract][Full Text] [Related]
9. Malignant sweat gland tumours: an update.
Cardoso JC; Calonje E
Histopathology; 2015 Nov; 67(5):589-606. PubMed ID: 26114606
[TBL] [Abstract][Full Text] [Related]
10. Expression of oestrogen receptor-beta in apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Kasumi F; Sawabe M; Arai T; Hosoi T; Yoshimura N; Harada N; Younes M; Sakamoto G
Histopathology; 2007 Mar; 50(4):425-33. PubMed ID: 17448017
[TBL] [Abstract][Full Text] [Related]
11. Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiation.
Hibler BP; Barker CA; Hollmann TJ; Rossi AM
JAAD Case Rep; 2017 May; 3(3):259-262. PubMed ID: 28580412
[No Abstract] [Full Text] [Related]
12. Primary cutaneous cribriform apocrine carcinoma: Case report and literature review.
Wu JD; Changchien CH; Liao KS
Indian J Dermatol Venereol Leprol; 2018; 84(5):569-572. PubMed ID: 29735815
[TBL] [Abstract][Full Text] [Related]
13. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
Langel DJ; Yeatts RP; White WL
Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
[TBL] [Abstract][Full Text] [Related]
14. Histological and immunohistochemical analysis of apocrine breast carcinoma.
Matsuo K; Fukutomi T; Hasegawa T; Akashi-Tanaka S; Nanasawa T; Tsuda H
Breast Cancer; 2002; 9(1):43-9. PubMed ID: 12196721
[TBL] [Abstract][Full Text] [Related]
15. A case of primary signet-ring cell/histiocytoid carcinoma of the eyelid: immunohistochemical comparison with the normal sweat gland and review of the literature.
Iwaya M; Uehara T; Yoshizawa A; Kobayashi Y; Momose M; Honda T; Ota H
Am J Dermatopathol; 2012 Dec; 34(8):e139-45. PubMed ID: 22935888
[TBL] [Abstract][Full Text] [Related]
16. Apocrine (cutaneous) sweat gland carcinoma of axilla with signet ring cells: a diagnostic dilemma on fine-needle aspiration cytology.
Pai RR; Kini JR; Achar C; Rau A; Kini H
Diagn Cytopathol; 2008 Oct; 36(10):739-41. PubMed ID: 18773442
[TBL] [Abstract][Full Text] [Related]
17. Primary apocrine carcinoma of scalp: report of primary scalp cutaneous apocrine carcinoma indistinguishable from cutaneous metastasis of breast carcinoma.
Kim HK; Chung KI; Park BY; Bae TH; Kim WS; Lee TJ
J Plast Reconstr Aesthet Surg; 2012 Mar; 65(3):e67-70. PubMed ID: 22122891
[TBL] [Abstract][Full Text] [Related]
18. The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.
Kambayashi Y; Fujimura T; Furudate S; Lyu C; Hidaka T; Kakizaki A; Sato Y; Tanita K; Aiba S
Anticancer Res; 2018 Jan; 38(1):113-120. PubMed ID: 29277763
[TBL] [Abstract][Full Text] [Related]
19. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
Pardal J; Sundram U; Selim MA; Hoang MP
Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
[TBL] [Abstract][Full Text] [Related]
20. Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy-A case report.
Collette F; Hamoir M; Van Eeckhout P; D'Abadie P; Duprez T; Schmitz S; Machiels JP
Clin Case Rep; 2020 Dec; 8(12):3472-3478. PubMed ID: 33363954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
